Status:
COMPLETED
Feasibility of a Modular mHealth for Tailored Rehabilitation of Breast Cancer
Lead Sponsor:
Samsung Medical Center
Conditions:
Breast Cancer
Eligibility:
FEMALE
20-70 years
Phase:
NA
Brief Summary
This study investigated the feasibility of the novel modular mobile health (mHealth) for personalized rehabilitation and explored the participants' satisfaction and app data during treatment of breast...
Detailed Description
This is prospective, feasible, parallel study in post-operative patients with breast cancer and during treatment. Disability of Arm, Shoulder, Hands (DASH), Physical activity data (IPAQ-SF), Physical ...
Eligibility Criteria
Inclusion
- Unilateral breast cancer at TNM stage 0 \~ III
- Patients who will undergo the treatment (chemotherapy, radiation therapy, and hormone therapy) after surgery
- Patients who had a mobile phone (Android or iOS)
Exclusion
- \- Patients who have metastases or recurrence to other organs were excluded
Key Trial Info
Start Date :
April 22 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2021
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04781712
Start Date
April 22 2019
End Date
March 30 2021
Last Update
October 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, Gangnam-gu, South Korea, 06351